Kintara Therapeutics, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Academic Collaborations
    • Advisors
  • Pipeline
    • Overview
    • VAL-083
    • REM-001
  • Clinical Trials
  • News & Media
    • Press Releases
    • Publications and Abstracts
    • Presentations
    • Events
    • Recent News
  • Investors
    • Overview
    • Analyst Coverage
    • News / Events
    • Company Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact
  • Careers

Press Releases

Investors

Investors

  • Overview
  • Analyst Coverage
  • News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Stock Data
    • Overview
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Independent Directors
  • Investor Tools
    • Email Alerts
    • Contacts
    • RSS News Feed
  • News / Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts

DelMar Pharmaceuticals Updates VAL-083 Glioblastoma Clinical Trial Progress

May 16, 2014

DelMar Pharmaceuticals to Present Interim Clinical Data for Ongoing VAL-083 Glioblastoma Multiforme Trial at ASCO

May 14, 2014

Why is glioblastoma so deadly? DelMar discusses the need for new cancer research and treatments for Brain Tumor Awareness Month

May 1, 2014

DelMar Pharmaceuticals VAL-083 Clinical Trial in GBM Demonstrates Continued and Promising Progress at AACR

Apr 9, 2014

DelMar Pharmaceuticals Presents Promising Pre-clinical Data with VAL-083 in Lung Cancer

Apr 7, 2014

DelMar Pharmaceuticals to Present Two Abstracts at American Association of Cancer Research (AACR) Annual Meeting

Apr 2, 2014

DelMar Pharmaceuticals Gives Quarterly Shareholder Update and Announces Investor Conference Call

Mar 20, 2014

DelMar Pharmaceuticals to Present at the 26th Annual ROTH Capital Conference

Mar 4, 2014

DelMar Pharmaceuticals Provides Update on VAL-083 Glioblastoma Clinical Trial

Feb 26, 2014

DelMar Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com

Dec 9, 2013
RSS
    • 1...
    • 23
    • 24
    • 25
    • 26
    • 27
    • 28
    • 29
    • 30
    • 31
    • 32
    © 2022 Kintara Therapeutics, Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap Legal Information Manage Cookie Preferences